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The Role of Major Hepatic Resections 
for Liver Metastases from Colorectal Cancert 
Angelos A. Kambouris, MD* 
O f the more than 120,000 new patients with colorectal 
cancer in 1982 (1), at least 20% wil l develop liver metas-
tases either at initial presentation or after treatment of 
the primary lesion. The median survival in such patients 
has been variously estimated at between five and nine 
months (2), and in spite of treatment by chemotherapeu-
tic agents, only rarely do such patients survive five years 
(2,3). By contrast, patients who survive the longest after 
treatment of liver metastases f rom colorectal cancer 
have had major hepatic resections alone or combined 
with chemotherapy as part of their management (4-9). 
The present report describes five patients who were 
treated for liver metastases by anatomic hepatic lobec-
tomy, either alone or combined with other treatment 
approaches. 
Materials 
Five patients have been treated by anatomic hepatic 
lobectomy bythe author since 1978 (Table I). There were 
four men and one woman, ranging in age f rom 39 to 71 
years. The rectum was the primary site in three patients, 
the sigmoid in one, and the descending colon in the 
f i f th. Whi le liver metastases were detected within six to 
19 months after initial treatment in three patients, they 
were present at the t ime of diagnosis of the primary 
tumor in the remaining two. Three of the patients had 
undergone no treatment for liver metastases before 
hepatic resection was undertaken. One had been treated 
by means of hepatic artery infusion wi th 5-fluoro-2-
deoxy-uridine (FUDR) for approximately 13 months, and 
his disease apparently stabilized. Hepatectomy was 
undertaken when he developed gradually rising carcino-
embryonicant igen (CEA) in the absence of extrahepatic 
metastases. The last patient presented with advanced 
liver dysfunction due to metastases, markedly decreased 
performance status, jaundice, and weight loss. At the 
t ime of sigmoid resection for treatment of his primary 
cancer, the right hepatic artery was ligated, and the 
patient was treated by systemic chemotherapy. 
No deaths resulted f rom hepatectomy in this small 
series, and only one patient developed a major compl i -
cation, which delayed her discharge by approximately 
12 days. 
Case 1 
A 47-year-old white man had undergone abdomino-
perineal resection for carcinoma of the rectum in Sep-
tember 1974. No metastases to the liver were found at 
operat ion. In June 1975, he developed hepatomegaly, 
and mult iple liver metastases were detected by liver 
scan. After extrahepatic metastases were excluded, a 
catheter was surgically introduced into the hepatic 
artery in June 1975, and the patient was treated with 
continuous infusion of 5-FUDR (0.3 mg/kg/day) for 
about 13 months, by means of a Watkins chronofusor 
pump®. His disease stabilized, but treatment was inter-
rupted because of catheter dysfunction. In 1977, he 
developed a splenic and left subphrenic abscess, attrib-
uted to the inlying hepatic artery catheter. Splenectomy 
and drainage of the abscess were carried out, and the 
catheter was removed. In January 1978, the CEA levels 
started to rise; a detailed evaluation over a f ive-month 
period showed no extrahepatic metastases. In May 1978, 
an anatomic right hepatic lobectomy was performed 
through a thoraco-abdominal incision for a mult i lobu-
lated metastatic mass. He recovered from the operation 
wel l , and the CEA levels reverted to normal. 
He remains asymptomatic four and a half years later, 
wi thout further treatment. Although it is not possible to 
speculate on the course of his disease had resection not 
been performed, the fact that active carcinoma was 
found in the resected specimen, thatthe CEA levels have 
remained normal, and that the patient has remained 
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asymptomatic all strongly suggest the beneficial effectof 
operation. 
Case 2 
A 56-year-old white man underwent low anterior re-
section for carcinoma of the rectosigmoid colon in 
September 1978. At operat ion, a solitary metastases 
was found in the left lobe of the liver, adjacent to the 
falciform ligament. Upon oncological evaluation, he was 
advised against chemotherapy, since he had asympto-
matic metastatic disease. The patient consented to left 
hepatic lobectomy after a six-month observation and 
reevaluation, during which t ime no extrahepatic disease 
developed. At operation in Apri l 1979, a 6 cm lymph 
node was also removed from the supraduodenal re-
gion and was found to be replaced by metastatic 
adenocarcinoma. 
The patient had an uneventful recovery and remained 
asymptomatic for twenty months wi thout further treat-
ment. He then developed regional recurrence with 
obstructive jaundice, which was treated with a percu-
taneously inserted biliary drainage catheter and sys-
temic chemotherapy. His disease has remained stable 
for the last twenty months, although on several occa-
sions he has been hospitalized for treatment of catheter 
obstruction and cholangitis. Although it would be 
impossible to predict the clinical course of this patient 
had he not undergone resection of his metastasis, one 
can assume that the disease process would have ad-
vanced, making subsequent treatment diff icult. 
Case 3 
A 68-year-old white man had undergone abdomino-
perineal resection in December 1978 for carcinoma of 
the rectum. In June 1981, he presented with clinical and 
radiographic evidence of metastases to the right lobe of 
the liver. A thorough evaluation, including bone scans 
and pelvic radiographs for pain in the bony pelvis, failed 
to demonstrate metastases. After surgical and oncologi-
cal evaluation, he underwent a right hepatic lobectomy 
for a large metastatic mass to the dome of the right lobe 
of the liver. 
He was discharged on the 12th postoperative day after 
an uneventful recovery. However, his pelvic pain per-
sisted, and in September 1981, three months after hepa-
tectomy, he was found to have large pelvic bone metas-
tases. In retrospect, in spite of the 18-month interval 
between the treatment of the primary carcinoma and 
the development of the liver metastases, this patient 
harbored extrahepatic disease at the t ime of hepatic 
resection. Bone pain had been the only clue to the 
existence of metastases, and bone scans were not help-
ful . For this patient, no long-term benefit was derived 
from major liver resection, although the operation at the 
time was based on sound principles. 
Case 4 
A 49-year-old white man was found to have a carcinoma 
of the sigmoid colon, in the course of diagnostic work-
up for massive right hepatic metastases, abnormal liver 
functions, weight loss, and markedly decreased perform-
ance status. The left lobe of the liver appeared normal on 
a liver scan, and no extrahepatic metastases were de-
tected. A visceral angiogram showed a dual arterial 
supply to the liver: the right hepatic artery originated 
f rom the superior mesenteric, and the left lobe was 
supplied by the proper hepatic artery. The gastroduode-
nal artery was normal. A two-stage approach was planned, 
in view of the patient's diminished performance status 
and marked hepatic dysfunction. In Apri l 1981, a sigmoid 
resection was per formed; a tumor occupying about 80% 
of the right lobe of the liver was also biopsied, and a 
nodule in the lateral segment o f the left lobe o f the liver, 
which was found to be cancerous, was excised. The right 
hepatic artery was doubly ligated, and several enlarged, 
clinically malignant nodes in the supraduodenal region 
were biopsied; on permanent section, they were found 
to be benign, hyperplastic nodes. After three days of 
fever and increasing levels of hepatic enzymes, the 
patient steadily improved. 
He had an uncomplicated postoperative course and was 
discharged on the 11th postoperative day. He was sub-
sequently treated with systemic chemotherapy (5-FU) 
and improved dramatically. His liver functions returned 
to near normal levels, he gained weight, and his perform-
ance status returned to normal. In October 1981, through 
a thoracoabdominal incision, a right hepatic lobectomy 
and wedge resection of the lateral segment of the left 
lobe were carried out. Both specimens showed carci-
noma, although there was necrosis in the central port ion 
of the tumor of the right lobe. An effort to insert a 
catheter into the proper hepatic artery via the gastro-
duodenal artery for infusion chemotherapy was unsuc-
cessful. After he was discharged f rom the hospital, 
chemotherapy was resumed and continues to date. The 
patient remains asymptomatic one year after hepatectomy. 
Case 5 
A 39-year-old white woman underwent left colectomy 
for carcinoma of the descendingcolon in Apr i l1981. No 
liver metastases were found at operation. Six months 
later, while investigating her for rising CEA levels, we 
detected a large solitary metastasis on the dome of the 
right lobe of the liver. In January 1982, two days after 
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visceral arteriograms were obtained using the right fem-
oral artery for catheter insertion, a right hepatic lobec-
tomy was performed through a thoracoabdominal ap-
proach. On the f i f th postoperative day, she developed 
right i l iofemoral thrombophlebit is which required anti-
coagulant therapy and elastic support. 
She was discharged on the 23rd postoperative day and 
remains on anticoagulant therapy. Al though she has 
remained asymptomatic and has gained weight, nine 
months after hepatectomy, her CEA levels are currently 
rising. Despite no objective evidence of disease, it is 
presumed that she harbors metastases. 
Discussion 
The treatment of patients with liver metastases f rom 
colorectal cancer remains controversial. Hepatic resec-
tions for treatment of primary and metastatic tumors of 
the liver were introduced in the late 1800s. By 1899 Keen 
(10) was able to summarize 76 reported cases from the 
literature and to document a surgical mortality of 14.9% 
in 59 cases in which the procedure was adequately de-
scribed. The same high mortality fol lowing major hepatic 
resections was documented by Lortat-Jacob and Robert 
in 1952 (11), Quatt lebaum in 1953 (12), Pack and Baker in 
1953 (13), Brunschwig in 1953 (14), and by Pack, Mi l ler , 
and Brasfield in 1955 (15). The resurgence of interest in 
major hepatectomies in the 1950s was stimulated in part 
by Healey's description o f the segmental anatomy o f the 
liver in 1954 (16), and in part by the emphasis on more 
extended operations performed in efforts to control 
cancer. Adson and Beart summarized the historical 
background of major hepatic resections in 1977 (17). 
The high surgical mortality after hepatic resection and 
the simultaneous discovery of mult iple antineoplastic 
compounds in the 1950s, along with the ease of adminis-
tration and the theoretical advantages of simultaneous 
treatment of mult iple sites, diverted efforts from surgical 
to chemotherapeutic management of patients with liver 
metastases. Al though systemic chemotherapy continues 
to play a role in 1982, its effectiveness in treating patients 
with liver metastases has remained low, with response 
rates averaging 20% (2,18), in spite of a variety of agents 
used alone or in combinat ion. In efforts to improve the 
effectiveness of chemotherapy to the liver whi le avoid-
ing systemic toxicity, Sullivan, et al (19) popularized pro-
longed hepatic intraarterial infusion chemotherapy, 
using a permanently inserted catheter into the hepatic 
artery and a portable external pump for continuous 
delivery of antimetabolites, usually FUDR. Infusion 
chemotherapy for primary as well as metastatic cancer to 
the liver has found a l imited butdefini teacceptanceasa 
treatment approach; it has facilitated the development 
of innovative combinations of drugs, isotopes, or con-
current use of radiation therapy. Its effectiveness has 
TABLE I 
Clinical and Operat ive Oetails in Patients Undergo ing Hepatic Lobectomy for Metastases f r om Colorectal Cancers 
Interval to Hospital stay 
A g e / Primary Metastases Prior t reatment Postoper-
No Sex Locat ion " r e a t m e n t (mos) of metastases Procedure Compl ica t ions ative Results Comments 
1 50, M Rectum A-P. resect ion 8 Hepat ic artery Right hepat ic N o n e 19 days Free of Had splenectomy and 
Sept. 1974 in fus ion for over lobec tomy cancer drainage of sub-
12 mos Apr i l 1978 Sept. 1982 phren ic abscess 
March 1977 
2 57, M Rectum Low anter ior 0 N o n e Left hepat ic None 10 days Recurrence O n bil iary drainage 
resect ion lobec tomy w i th jaund ice and chemotherapy 
Sept. 1978 excision of Dec. 1980 Sept. 1982 
cellar 1. nodes 
Apr i l 1979 
3 7 1 , M Rectum A-P. resect ion 18 N o n e Right hepat ic None 12 days Pelvic bone Bone scan and 
Dec. 1978 lobectomy metastases radiographs 
June 1981 Sept. 1981 negative 
June 1981 
4 49, M Sigmoid Sigmoid resec- 0 Right hepat ic Right hepat ic None 11 days Free of cancer Presented w i th 
co lon t i o n ; r ight artery l igat ion; l obec tomy ; wedge Oc t . 1982 massive liver metas-
hepatic artery chemotherapy excision nodu le O n mainte- tases. Dramat ic 
l igat ion; biopsy (5-FU) of left lobe of nance chemo- response to hepat ic 
left lobe of liver for 6 mos liver therapy artery l igat ion and 
and hilar nodes chemotherapy be fore 
Apr i l 1982 hepatectomy 
5 39, F Descend- Left co lec tomy 6 N o n e Right hepat ic I l io femora l 23 days Asymptomat ic Thromboph leb i t i s 
ing Apr i l 1981 lobec tomy t h r o m b o - rising CEA at site of femora l 
co lon Jan. 1982 phlebi t is metastases artery punc tu re two 
suspected days be fore 
Sept. 1982 hepatectomy 
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increased response rates to over 60%; and it has pro-
longed median survival in patients with metastases from 
colorectal cancers (2,5). Its role has recently been 
enhanced by the development of a totally implantable 
pump delivery system, obviating many of the pump and 
catheter-related complications (20). The effect of infu-
sion chemotherapy, although it appears favorable, wil l 
require time for definite assessment. 
Becauseof the lackof success of systemic chemotherapy 
and the promising but uncertain effectiveness of infu-
sion chemotherapy, the interest in hepatic resections to 
treat liver metastases from colorectal cancer has been 
revived in the past ten years. Stimulating reports by 
Wilson and Adson in 1976 (4), fol lowed by reports by 
others (2,4-9), and by refinements in surgical techniques 
as described by McBride (5) and Starzl (21), are primarily 
responsible. Adson, et al (9), in summarizing the Mayo 
Clinic experience in 1980, stated that 4 1 % of 32 patients 
surviving hepatic resections lived three or more years, 
three patients were alive f rom 10 to 22 years, and 20-30% 
of all patients benefited from hepatic resection regard-
less of how long they survived. Similarly, Logan, et al (2) 
reported three of 19 patients who survived more than 
five years and one who survived eight years after major 
hepatic resection for metastases from colorectal cancer. 
The most comprehensive survey, however, was under-
taken by Foster (7,8), who summarized the cases of more 
than four hundred patients undergoing hepatic resec-
tions for treatment of liver metastases. He calculated an 
overall surgical mortality of 11%, but the rate was only 
6% for 125 patients operated for metastases from colo-
rectal cancers. Among those who survived the opera-
t ion, the five-year survival rate ranged f rom 19% to 26%. 
Patients with solitary metastases did better than those 
with mult iple lesions, and the results were inversely 
affected by the extent of the operation. As a resu it of that 
review, Foster strongly recommends an aggressive 
approach to liver metastases from colorectal cancer, 
while surgical treatment of metastases from other organs 
should be approached on an individual basis. 
The benefits of hepatectomy in our patients need to be 
evaluated on an individual basis also. There is little doubt 
that the first patient benefited from resection of the only 
known metastases. The fact that he remains asympto-
matic four and a half years later with a normal CEA level 
justifies the rationale for the operation. Likewise, the 
fourth patient derived definite benefit f rom the hepatic 
artery ligation initially, the interval systemicchemother-
apy, and the right hepatic lobectomy six months later. 
Whether the wedge excision of a solitary metastasis from 
the lateral segment o f the left lobe wil l affect the clinical 
course remains to be seen. Lack of symptoms and nor-
mal performance status 12 months later attest to the 
effectiveness of operation so far. In the second patient, 
the effect of left hepatic lobectomy and excision of a 
large nodal metastasis would be impossible to ascertain. 
Al though the patient remained totally asymptomatic for 
twenty months, he was asymptomatic at the t ime of 
operation also. The development of bony metastases 
only three months after hepatectomy in the third patient 
negates any benefits he might otherwise have derived. It 
is well known to clinicians that pelvic bony pain is a 
significant premonitor of recurrent or metastatic disease 
after abdomino-perineal resection for rectal cancers. 
Because of this suspicion, diagnostic work-up had been 
detailed but failed to detect preclinical metastases 
before hepatectomy. In the f i f th patient, the benefit is 
obviously minimal as she developed abnormal CEA lev-
els six months after hepatectomy, in spite of her excel-
lent performance status. However, stem cell assay o f the 
resected metastasis showed no effect o f t h e commonly 
used chemotherapeutic agents in this patient, which 
indicates that using chemotherapy as an alternate to 
resectional treatment would likewise have failed. From 
that point of view, in addition to removing the only 
known metastasis at the t ime, the procedure afforded 
important information which might influence future 
management whenever metastases become recognized. 
The successful recovery of all five patients, the minimal 
postoperative hospital stay, and the lack of complica-
tions in four of the five make hepatic lobectomy attrac-
tive when compared to a less effective but definitely 
more symptomatic systemic chemotherapy. 
Summary 
Major hepatic resections have assumed an important 
role in treating liver metastases for colorectal cancers. 
They are particularly indicated for solitary or even clus-
tered unilobar metastases, when the primary tumor has 
been control led. The mortality rates of approximately 
6% and the reported disease-free, five-year rates of over 
20% indicate that such resections have become safe and 
are feasible under proper conditions. 
Among our five patients undergoing hepatic lobectomy, 
there were no deaths and only one complication. One 
patient remains asymptomatic at four and a half years, 
one suffered a recurrence after twenty months, and the 
third developed bone metastases within three months of 
operation. The fourth patient remains asymptomatic at 
12 months but is receiving maintenance chemotherapy; 
and the f i f th , while asymptomatic, is suspected to harbor 
metastases nine months after hepatectomy. 
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This experience is too l imited to allow conclusions on its 
own merits. However, it agrees with information in the 
surgical literature which justifies the consideration of 
heptic lobectomy for solitary liver metastases f rom colo-
rectal cancer as an alternative to or in conjunct ion with 
systemic chemotherapy. Given the individual selection 
process in the reported surgical series, and the variety of 
nonresective therapeutic regimens, a control led clinical 
trial would be the most objective mechanism to evaluate 
the efficacy of major hepatic resections for treating 
patients with liver metastases from colorectal cancer. 
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